Decision Aid for the Covid-19 Vaccine

The CRA, with input from the Canadian Arthritis Patient Alliance (CAPA) has developed a Decision Aid for the COVID-19 Vaccine in Patients with Autoimmune Rheumatic Diseases.

By |2021-03-18T14:32:02+00:00January 21st, 2021|Comments Off on Decision Aid for the Covid-19 Vaccine

Clinical Resources

The Canadian Scleroderma Research Group teamed up with the Australian Scleroderma Interest Group to developed a new set of inclusion/exclusion criteria for stem cell transplantation that can act as guide to Canadian rheumatologists.

By |2020-08-05T19:43:31+00:00November 19th, 2017|Comments Off on Clinical Resources
Go to Top